Effects of vestibular rehabilitation, with or without betahistine, on managing residual dizziness after successful repositioning manoeuvres in patients with benign paroxysmal positional vertigo: a protocol for a randomised controlled trial

Peixia Wu, Wenzhu Cao, Yan Hu, Huawei Li, Peixia Wu, Wenzhu Cao, Yan Hu, Huawei Li

Abstract

Introduction: Benign paroxysmal positional vertigo (BPPV) is recognised as the leading cause of peripheral vertigo in adults. The canalith repositioning procedure (CRP) can be used for effective treatment of BPPV. However, some patients experience residual dizziness (RD) even after successful CRP, resulting in a significant negative impact on their daily function and quality of life. Exercise-based vestibular rehabilitation (VR) has been proven as an effective method for managing dizziness and has been applied in patients with various vestibular disorders. However, the efficacy of VR to specifically target RD post-BPPV is unknown. This study aims to investigate the efficacy of VR, compared with betahistine or VR plus betahistine treatment, in the treatment of patients experiencing RD after successful CRP.

Methods and analysis: A randomised single-blinded controlled trial will be carried out to determine the efficacy of VR compared with betahistine or VR plus betahistine treatment in mitigating RD and improving balance function. Patients with BPPV who experience RD after successful CRP will be recruited. Participants will be randomised into one of three groups to receive VR, betahistine or VR plus betahistine. There will be 61 participants in each group. The primary outcomes will be changes in the patient's daily function as measured by the Vestibular Activities and Participation questionnaire and balance ability assessed by computerised dynamic posturography. The secondary outcomes will be dizziness-related handicap, otolith function and duration of RD symptoms. Outcome measures will be noted at baseline and at 2, 4 and 8 weeks post-randomisation. This study has the potential to reduce unnecessary anti-vertigo drug prescriptions and may lead to a general consensus regarding the use of VR as a first-line treatment for RD in patients with BPPV.

Ethics and dissemination: This trial received ethical approval from the Institutional Review Board of Eye and ENT Hospital of Fudan University (reference number 2017046). The study results will be disseminated via peer-reviewed journals and conferences.

Trial registration number: NCT03624283; Pre-results.

Keywords: benign paroxysmal positional vertigo; dizziness; randomised controlled trial; vestibular rehabilitation.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
Screenshot of head movement exercises in the training video.
Figure 3
Figure 3
Screenshot of gait exercise in the training video.

References

    1. von Brevern M, Radtke A, Lezius F, et al. . Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 2007;78:710–5. 10.1136/jnnp.2006.100420
    1. Kim JS, Zee DS. Clinical practice. Benign paroxysmal positional vertigo. N Engl J Med 2014;370:1138–47. 10.1056/NEJMcp1309481
    1. Schuknecht HF, Ruby RR. Cupulolithiasis. Adv Otorhinolaryngol 1973;20:434–43.
    1. Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992;107:399–404. 10.1177/019459989210700310
    1. Brandt T, Steddin S. Current view of the mechanism of benign paroxysmal positioning vertigo: cupulolithiasis or canalolithiasis? J Vestib Res 1993;3:373–82.
    1. Inagaki T, Suzuki M, Otsuka K, et al. . Model experiments of BPPV using isolated utricle and posterior semicircular canal. Auris Nasus Larynx 2006;33:129–34. 10.1016/j.anl.2005.09.001
    1. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. . Clinical practice guideline: benign paroxysmal positional vertigo (Update). Otolaryngol Head Neck Surg 2017;156(3_suppl):S1–S47. 10.1177/0194599816689667
    1. Martellucci S, Pagliuca G, de Vincentiis M, et al. . Features of Residual Dizziness after Canalith Repositioning Procedures for Benign Paroxysmal Positional Vertigo. Otolaryngol Head Neck Surg 2016;154:693–701. 10.1177/0194599815627624
    1. Swain SK BI, Mc S. Role of Ginkgo biloba for controlling residual dizziness after successful treatment of benign paroxysmal positional vertigo: Our experiences at a tertiary care teaching hospital of Eastern India. Int J health Allied Sci 2018;7:196–200.
    1. Seok JI, Lee HM, Yoo JH, et al. . Residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigo. J Clin Neurol 2008;4:107–16. 10.3988/jcn.2008.4.3.107
    1. Giommetti G, Lapenna R, Panichi R, et al. . Residual Dizziness after Successful Repositioning Maneuver for Idiopathic Benign Paroxysmal Positional Vertigo: A Review. Audiol Res 2017;7:31–7. 10.4081/audiores.2017.178
    1. Vaduva C, Estéban-Sánchez J, Sanz-Fernández R, et al. . Prevalence and management of post-BPPV residual symptoms. Eur Arch Otorhinolaryngol 2018;275:1429–37. 10.1007/s00405-018-4980-x
    1. Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, et al. . Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 2005;262:507–11. 10.1007/s00405-004-0841-x
    1. Korres S, Balatsouras DG, Ferekidis E. Prognosis of patients with benign paroxysmal positional vertigo treated with repositioning manoeuvres. J Laryngol Otol 2006;120:528–33. 10.1017/S0022215106000958
    1. Faralli M, Lapenna R, Giommetti G, et al. . Residual dizziness after the first BPPV episode: role of otolithic function and of a delayed diagnosis. Eur Arch Otorhinolaryngol 2016;273:3157–65. 10.1007/s00405-016-3947-z
    1. Seo T, Shiraishi K, Kobayashi T, et al. . Residual dizziness after successful treatment of idiopathic benign paroxysmal positional vertigo originates from persistent utricular dysfunction. Acta Otolaryngol 2017;137:1149–52. 10.1080/00016489.2017.1347824
    1. Kim HA, Lee H. Autonomic dysfunction as a possible cause of residual dizziness after successful treatment in benign paroxysmal positional vertigo. Clin Neurophysiol 2014;125:608–14. 10.1016/j.clinph.2013.08.008
    1. Staab JP, Eckhardt-Henn A, Horii A, et al. . Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res 2017;27:191–208. 10.3233/VES-170622
    1. Rubenstein LZ, Kenny RA, Eccles M, et al. . Preventing falls in older people: new advances and the development of clinical practice guidelines. J R Coll Physicians of Edinb 2003;33:262–72.
    1. Abou-Elew MH, Shabana MI, Selim MH, et al. . Residual postural instability in benign paroxysmal positional vertigo. Audiol Med 2011;9:8–15. 10.3109/1651386X.2010.537121
    1. Teggi R, Giordano L, Bondi S, et al. . Residual dizziness after successful repositioning maneuvers for idiopathic benign paroxysmal positional vertigo in the elderly. Eur Arch Otorhinolaryngol 2011;268:507–11. 10.1007/s00405-010-1422-9
    1. van Vugt VA, van der Horst HE, Payne RA, et al. . Chronic vertigo: treat with exercise, not drugs. BMJ 2017;358:j3727 10.1136/bmj.j3727
    1. Guneri EA, Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012;146:104–8. 10.1177/0194599811419093
    1. Acar B, Karasen RM, Buran Y. Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo (BPPV). B-ENT 2015;11:117–21.
    1. Hillier SL, McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Db Syst Rev 2011;2:CD005397.
    1. Hall CD, Herdman SJ, Whitney SL, et al. . Vestibular Rehabilitation for Peripheral Vestibular Hypofunction: An Evidence-Based Clinical Practice Guideline: from the American physical therapy association neurology section. J Neurol Phys Ther 2016;40:124–55. 10.1097/NPT.0000000000000120
    1. Shepard NT, Telian SA, Smith-Wheelock M. Habituation and balance retraining therapy. A retrospective review. Neurol Clin 1990;8:459–75.
    1. Herdman SJ, Blatt PJ, Schubert MC. Vestibular rehabilitation of patients with vestibular hypofunction or with benign paroxysmal positional vertigo. Curr Opin Neurol 2000;13:39–43. 10.1097/00019052-200002000-00008
    1. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. . Clinical practice guideline: benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2017;156:S1–S47. 10.1177/0194599816689667
    1. Hillier SL, McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Clin Otolaryngol 2011;36:248–9. 10.1111/j.1749-4486.2011.02309.x
    1. Bressi F, Vella P, Casale M, et al. . Vestibular rehabilitation in benign paroxysmal positional vertigo: Reality or fiction? Int J Immunopathol Pharmacol 2017;30:113–22. 10.1177/0394632017709917
    1. Chang WC, Yang YR, Hsu LC, et al. . Balance improvement in patients with benign paroxysmal positional vertigo. Clin Rehabil 2008;22:338–47. 10.1177/0269215507082741
    1. Ribeiro KM, Freitas RV, Ferreira LM, et al. . Effects of balance Vestibular Rehabilitation Therapy in elderly with Benign Paroxysmal Positional Vertigo: a randomized controlled trial. Disabil Rehabil 2017;39:1198–206. 10.1080/09638288.2016.1190870
    1. Otto V, Fischer B, Schwarz M, et al. . Treatment of vertebrobasilar insufficiency–associated vertigo with a fixed combination of cinnarizine and dimenhydrinate. Int Tinnitus J 2008;14:57–67.
    1. Murdin L, Hussain K, Schilder AG. Betahistine for symptoms of vertigo. Cochrane Db Syst Rev 2016;6:D10696.
    1. Dziura JD, Post LA, Zhao Q, et al. . Strategies for dealing with missing data in clinical trials: from design to analysis. Yale J Biol Med 2013;86:343–58.
    1. Grill E, Bronstein A, Furman J, et al. . International Classification of Functioning, Disability and Health (ICF) Core Set for patients with vertigo, dizziness and balance disorders. J Vestib Res 2012;22:261–71. 10.3233/VES-120459
    1. Alghwiri AA, Whitney SL, Baker CE, et al. . The development and validation of the vestibular activities and participation measure. Arch Phys Med Rehabil 2012;93:1822–31. 10.1016/j.apmr.2012.03.017
    1. Mueller M, Whitney SL, Alghwiri A, et al. . Subscales of the vestibular activities and participation questionnaire could be applied across cultures. J Clin Epidemiol 2015;68:211–9. 10.1016/j.jclinepi.2014.10.004
    1. Nashner LM. Computerized dynamic posturography : Jacobson GP SNE, Balance Function Assessment and Management. San Diego: Plural Publishing, 2016.
    1. Ding L, Liu C, Wang JX. An Evaluaiton of the Dizziness Handicap Inventory (Chinese version). Chinese Journal of Otology 2013;11:228–30. In Chinese.
    1. Hoseinabadi R, Pourbakht A, Yazdani N, et al. . The effects of abnormality of cVEMP and oVEMP on rehabilitation outcomes in patients with idiopathic benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol 2016;273:643–8. 10.1007/s00405-015-3612-y
    1. Tian YS, Zhang Y, Ma R, et al. . [Features of vestibular evoked myogenic potential in patients with residual dizziness after canalith repositioning procedures for benign paroxysmal positional vertigo]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018;32:845–9. In Chinese 10.13201/j.issn.1001-1781.2018.11.011
    1. Zhou YJ, Wu YZ, Cong N, et al. . Contrasting results of tests of peripheral vestibular function in patients with bilateral large vestibular aqueduct syndrome. Clin Neurophysiol 2017;128:1513–8. 10.1016/j.clinph.2017.05.016

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj